Home › Funds › Aisling Capital Management LP › ACRS

Aisling Capital Management LP position in ACRS

ACLARIS THERAPEUTICS INC · Health Care

Aisling Capital Management LP reported holding 434,455 shares of ACRS (ACLARIS THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$2.3M, representing 0.76% of its reported portfolio and ranking #10 among its reported holdings. Aisling Capital Management LP has disclosed ACRS holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)434.45K sh
Reported value held$2.29M
Portfolio Weight0.76%
First reportedQ3 2023
Last changeHold
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Aisling Capital Management LP's ACRS position evolved

Aisling Capital Management LP first disclosed a stake in ACRS in Q3 2023 at 434,455 shares (US$3.0M). Across 13 filings, Aisling Capital Management LP held the position steady without any share-count change. The most recent filing (Q3 2026) shows 434,455 shares valued at US$2.3M.

Quarter by quarter

QuarterSharesValueChange
Q3 2023 434.45K $2.98M New
Q4 2023 434.45K $456.18K Hold
Q1 2024 434.45K $538.72K Hold
Q2 2024 434.45K $477.90K Hold
Q3 2024 434.45K $499.62K Hold
Q4 2024 434.45K $1.08M Hold
Q1 2025 434.45K $664.72K Hold
Q2 2025 434.45K $616.93K Hold
Q3 2025 434.45K $825.47K Hold
Q4 2025 434.45K $1.31M Hold
Q1 2026 434.45K $1.63M Hold
Q2 2026 434.45K $2.30M Hold
Q3 2026 434.45K $2.29M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ACRS and 13F data

ACRS (ACLARIS THERAPEUTICS INC) is a Health Care company. 44 other funds we track also report a position in ACRS — the largest reported positions include RA CAPITAL MANAGEMENT, L.P. (US$67.3M), BML Capital Management, LLC (US$57.6M), Deep Track Capital, LP (US$49.4M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ACRS

All ACRS fund holders →

FAQ

How long has Aisling Capital Management LP held ACRS?

Aisling Capital Management LP has disclosed ACRS holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is Aisling Capital Management LP's current position in ACRS?

As of Q3 2026, Aisling Capital Management LP holds 434.45K shares of ACRS (ACLARIS THERAPEUTICS INC), valued at $2.29M, representing 0.76% of its reported portfolio and ranking #10.

Has Aisling Capital Management LP been buying or selling ACRS?

In the latest 13F filing (Q3 2026), Aisling Capital Management LP held unchanged its position in ACRS.

Which other funds hold ACRS?

Other major institutional holders of ACRS include RA CAPITAL MANAGEMENT, L.P., BML Capital Management, LLC, Deep Track Capital, LP, among 44 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.